Medicare Enrolled

Dr. George Fadda, M.D.

Nephrology · La Mesa, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
8851 CENTER DR, La Mesa, CA 91942
6194613880
In practice since 2005 (20 years)
NPI: 1619972247 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fadda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fadda? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fadda

Dr. George Fadda is a nephrology specialist in La Mesa, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Fadda performed 2,867 Medicare services across 1,188 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fadda received a total of $190,860 from 34 pharmaceutical and/or device companies across 287 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fadda is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 19% volume in CA $190,860 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,867
Medicare services
Top 19% in CA for nephrology
1,188
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~143 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
970 $65 $157
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
644 $63 $235
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
402 $98 $222
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
335 $293 $617
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
182 $48 $162
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
136 $142 $428
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
58 $107 $315
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
52 $244 $542
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
40 $41 $95
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
34 $135 $352
Hemodialysis, single evaluation
A dialysis procedure to filter waste from the blood, performed with a physician's evaluation.
14 $59 $158
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$190,860
Total received (2018-2024)
Avg $27,266/year across 7 years
Top 2% in CA for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
287
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$94,238 (49.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$93,672 (49.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,950 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$29,378
2023
$33,343
2022
$65,996
2021
$34,701
2020
$16,350
2019
$778
2018
$10,313

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Otsuka Pharmaceutical Development & Commercialization, Inc.
$8,736
GlaxoSmithKline, LLC.
$5,688
AstraZeneca Pharmaceuticals LP
$3,650
ABBVIE INC.
$3,000
AKEBIA THERAPEUTICS INC
$2,420
Bayer Healthcare Pharmaceuticals Inc.
$2,300
CALLIDITAS THERAPEUTICS US INC.
$1,869
AstraZeneca UK Limited
$1,264
Janssen Pharmaceuticals, Inc
$149
Ardelyx, Inc.
$146
Boehringer Ingelheim Pharmaceuticals, Inc.
$71
Aurinia Pharma U.S., Inc.
$52
NXSTAGE MEDICAL, INC.
$33
Top 3 companies account for 61.5% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$50,898
AstraZeneca Pharmaceuticals LP
$49,797
GlaxoSmithKline, LLC.
$30,571
Calliditas Therapeutics US Inc.
$11,376
Otsuka Pharmaceutical Development & Commercialization, Inc.
$9,607
SCPHARMACEUTICALS INC.
$5,632
Vifor Pharma, Inc.
$5,000
Keryx Biopharmaceuticals, Inc.
$4,990
OPKO Pharmaceuticals, LLC
$4,959
Horizon Therapeutics plc
$4,503
ABBVIE INC.
$3,000
AKEBIA THERAPEUTICS INC
$2,557
Bayer Healthcare Pharmaceuticals Inc.
$2,550
CALLIDITAS THERAPEUTICS US INC.
$1,869
AstraZeneca UK Limited
$1,264
Otsuka America Pharmaceutical, Inc.
$522
Aurinia Pharma U.S., Inc.
$201
La Jolla Pharmaceutical Company
$195
Astute Medical, Inc.
$165
Janssen Pharmaceuticals, Inc
$149
Ardelyx, Inc.
$146
Relypsa, Inc.
$125
CVRx, Inc.
$122
Alexion Pharmaceuticals, Inc.
$121
Mallinckrodt Enterprises LLC
$121
Amgen Inc.
$76
Fresenius USA Marketing, Inc.
$73
Boehringer Ingelheim Pharmaceuticals, Inc.
$71
AMAG Pharmaceuticals, Inc.
$44
Allergan Inc.
$41
Daiichi Sankyo Inc.
$37
NXSTAGE MEDICAL, INC.
$33
Baxter Healthcare
$24
Novartis Pharmaceuticals Corporation
$20
Top 3 companies account for 68.8% of all-time payments
Associated products mentioned in payments ›
AURYXIA · Auryxia · BENLYSTA · BYSTOLIC · Barostim Neo System · ENTRESTO · EVUSHELD · FARXIGA · FERAHEME · FUROSCIX · GIAPREZA · IBSRELA · INJECTAFER · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · NXSTAGE SYSTEM ONE · Nephrocheck · OFIRMEV · Parsabiv · RAYALDEE · Rayaldee · Rayaldee (old) · Renal - PD · SAMSCA · TARPEYO · Vafseo · Velphoro · Veltassa · XARELTO · XPHOZAH 30 MG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (49%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nephrology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for nephrology in CA.

Looking for a nephrology specialist in La Mesa?
Compare nephrologists in the La Mesa area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
108
Per 100K population
3.3
County median income
$102,285
Nearest hospital
GROSSMONT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Fadda is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with speaking/promotional industry engagement in the top 2% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Fadda experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Fadda performed 970 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fadda receive payments from pharmaceutical companies?
Yes. Dr. Fadda received a total of $190,860 from 34 companies across 287 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fadda's costs compare to other nephrologists in La Mesa?
Dr. Fadda's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fadda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →